Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.41 |
| ▸ | RARB | P10826 | 9/20 | 0.40 |
| ▸ | RARG | P13631 | 8/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | RXRA | P19793 | 7/20 | 0.40 |
| ▸ | RARA | P10276 | 7/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.40 |
| ▸ | RXRB | P28702 | 3/20 | 0.40 |
| ▸ | RXRG | P48443 | 3/20 | 0.40 |
| ▸ | RORC | P51449 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | HTR2B | P41595 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.40 |
| ▸ | DRD3 | P35462 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8034537 | 0.85 | CYP1A2 (0.49) | CYP1A2HAO1RARBRARGALDH1A1 | |
| SCHEMBL9342959 | 0.83 | CYP1A2 (0.51) | CYP1A2HAO1RARBRARGALDH1A1 | |
| SCHEMBL3980038 | 0.82 | CYP1A2 (0.46) | CYP1A2HAO1RARBRARGALDH1A1 | |
| SCHEMBL9838256 | 0.82 | CYP1A2 (0.46) | CYP1A2HAO1RARBRARGALDH1A1 | |
| SCHEMBL9244543 | 0.80 | CYP1A2 (0.45) | CYP1A2HAO1RARBRARGALDH1A1 | |
| SCHEMBL9244539 | 0.80 | CYP1A2 (0.45) | CYP1A2HAO1RARBRARGALDH1A1 | |
| SCHEMBL11448119 | 0.80 | CYP1A2 (0.45) | CYP1A2HAO1RARBRARGALDH1A1 | |
| SCHEMBL11328784 | 0.80 | HAO1 (0.42) | CYP1A2HAO1RARBRARGALDH1A1 | |
| SCHEMBL18116771 | 0.80 | CYP1A2 (0.45) | CYP1A2HAO1RARBRARGALDH1A1 | |
| SCHEMBL3641236 | 0.79 | CYP1A2 (0.36) | CYP1A2HAO1RARBRARGALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025120108-A1 | ISOMERIZATION PROCESS | FIRMENICH SA (CH) | 2025-06-12 | — | — | WO | claimed |
| CN-110746283-A | Synthesis process of β -damascone | 新乡市博源生物科技有限公司 | 2020-02-04 | — | — | CN | claimed |
| JP-4268806-B2 | — | — | 2009-05-27 | — | — | JP | claimed |
| EP-1395542-B1 | CATALYTIC SYSTEM FOR ALDOL REACTIONS | FIRMENICH & CIE (CH) | 2006-08-16 | — | — | EP | claimed |
| US-6838575-B2 | Catalytic system for aldol reactions | FIRMENICH SA (CH) | 2005-01-04 | — | — | US | claimed |
| JP-2004529190-A | — | — | 2004-09-24 | — | — | JP | claimed |
| US-20040082818-A1 | Catalytic system for aldol reactions | FIRMENICH SA (CH) | 2004-04-29 | — | — | US | claimed |
| EP-1395542-A1 | CATALYTIC SYSTEM FOR ALDOL REACTIONS | FIRMENICH SA (CH) | 2004-03-10 | — | — | EP | claimed |
| WO-2002094755-A1 | CATALYTIC SYSTEM FOR ALDOL REACTIONS | FIRMENICH SA (CH) | 2002-11-28 | — | — | WO | claimed |
| US-4217252-A | Perfume compositions containing 1-acyl-2,6,6-trimethylcyclohexene derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-08-12 | — | — | US | claimed |
| US-4215704-A | Use in smoking tobacco compositions and smoking tobacco articles of 1-acyl-2,6,6-trimethylcyclohexene derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-08-05 | — | — | US | claimed |
| US-4210553-A | Detergent compositions containing 1-acyl-2,6,6-trimethylcyclohexene derivatives and processes for preparing same | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-07-01 | — | — | US | claimed |
| US-4209542-A | Process for augmenting or enhancing the aroma or taste of a foodstuff by adding to a foodstuff a mixture of 1-acyl-2,6,6-trimethylcyclohexene derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-06-24 | — | — | US | claimed |
| WO-2026047126-A1 | ISOMERIZATION OF 2,6,6-TRIMETHYLCYCLOHEX-1 OR 2-ENYL KETONES OR ESTERS CATALYZED BY STRONG BASE | FIRMENICH SA (CH) | 2026-03-05 | — | — | WO | disclosed |
| WO-2025120108-A1 | ISOMERIZATION PROCESS | FIRMENICH SA (CH) | 2025-06-12 | — | — | WO | disclosed |
| EP-2768307-B1 | OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE | BIKAM PHARMACEUTICALS INC (US) | 2020-03-18 | — | — | EP | disclosed |
| US-4209542-A | Process for augmenting or enhancing the aroma or taste of a foodstuff by adding to a foodstuff a mixture of 1-acyl-2,6,6-trimethylcyclohexene derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-06-24 | — | — | US | disclosed |
| US-4196306-A | 1-Acyl-2,6,6-trimethylcyclohexene derivatives, processes for producing same, intermediates therefor and organoleptic uses thereof | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-04-01 | — | — | US | disclosed |
| US-4172850-A | CATALYTIC HYDROGENATION OF ACYCLCYCLOHEXADIENE | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1979-10-30 | — | — | US | disclosed |
| US-3954804-A | Production of high molecular weight unsaturated ketones | BASF AKTIENGESELLSCHAFT (DT) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082818-A1 | Catalytic system for aldol reactions | AKR1B10, AGL, AKR1C2 | CYP1A2 161/4885HAO1 1033/4885RARB 4030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.